海倫哲(300201.SZ)拉昇漲近5% 子公司4款產品被列為抗疫裝備
格隆匯2月18日丨海倫哲(300201.SZ)午後出現拉昇走勢,目前漲幅擴大至4.89%報3.86元,暫成交9300萬元,最新總市值40.18億元。

海倫哲在互動平台上表示,公司全資子公司上海格拉曼國際消防裝備有限公司研發生產銷售的2款軍品(防化噴灑車、大規模人員洗消遠程供水車)和2款民品(洗消機器人、多劑聯用舉高噴灑消防車)被部隊列為抗擊疫情裝備,這2款民品還被上海市政府列為抗疫裝備。同時,公司針對此次疫情緊急研製了一款彌霧消毒洗消機器人已於近日交付試用。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.